全球解毒剂市场：按类型、给药途径、最终用户、地区

全球解毒剂市场规模预计将从2023年的27亿美元增加至2030年的45.8亿美元，预测期内复合年增长率为7.8%。

图 1. 2023 年全球市场占有率(%)（按地区）

由于世界各地中毒案例的增加，全球解毒剂市场在过去几年中一直稳步增长。中毒可能是由于摄入有毒化学物质、药物或其他有害物质而意外或故意发生的。解毒剂是用于抵消毒物、毒素或某些医疗状况的影响的药物製剂。解毒剂透过抑制毒物在体内发挥毒性的机制发挥作用。随着现代环境污染和药物滥用的加剧，针对有毒物质的有效抗蛇毒血清治疗的需求不断增加。市面上提供了多种常见中毒病例的解毒剂，包括鸦片类药物、有机磷酸盐、甲醇、Chloroquine和其他毒物。领先公司致力于开发具有更好功效和安全性的新颖配方，以满足未满足的需求。

市场动态：

全球意外和故意中毒事件的增加是解毒剂市场的主要驱动力。环境污染和工业废弃物的增加同时也增加了有毒化学物质的暴露。药物滥用疾病的显着增加也增加了因处方药和娱乐性药物过量摄取而上瘾的风险。然而，解毒剂生产成本高、部分产品保质期短以及偏远地区无法取得，在一定程度上限制了更广泛的市场吸收。同时，先进替代治疗方法的研发进展以及新兴国家医疗保健覆盖范围的扩大预计将创造新的机会。针对特定毒素和生物恐怖主义製剂的解毒剂的开发也具有广阔的前景。此外，需要使用解毒剂的医疗问题包括肺炎的预防性治疗、戒烟辅助、弓形虫病的治疗、对抗阿片类药物过量摄取、逆转阿片类药物引起的镇静、解决拔毛癖和逆转镇静。这种情况的不断增加也推动了市场的发展扩张。

本研究的主要特点

• 本报告对全球解毒剂市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球解毒剂市场的主要企业。
• 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球解毒剂市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过分析全球解毒剂市场时所使用的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 监管场景
• 服务交付组合
• PEST分析
• 波特的分析
• 併购场景

第四章全球解毒​​剂市场－冠状病毒（COVID-19）大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球解毒​​剂市场，按类型，2018-2030

• 介绍
• 化学解毒剂
• 物理解毒剂
• 药理解毒剂

第六章 全球解毒剂市场，依给药途径，2018-2030

• 介绍
• 口服
• 局部的
• 注射
• 其他的

第七章 全球解毒剂市场，按最终用户划分，2018-2030 年

• 介绍
• 医院
• 专科诊所
• 其他的

第八章2018-2030年全球解毒剂市场（按地区）

• 介绍
• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 东南亚国协
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争形势

• Reddy's Laboratories Ltd
• Viatris Inc.
• Fresenius Kabi AG
• Zydus Lifesciences Ltd.
• Endo International plc
• Novartis AG
• Baxter International, Inc.
• Emergent BioSolutions Inc.
• Pfizer Inc.
• Hikma Pharmaceuticals PLC
• Incepta Pharma
• VINS Bioproducts Ltd
• Bharat Serums and Vaccines Limited
• CSL Limited
• Mediclone Biotech
• Shanghai Serum Bio-technology Co., LTD.
• Haffkine Bio-pharmaceutical Corporation Ltd.
• Premium Serums

第10章

• 调查方法
• 关于出版商

The global antidote market size is expected to reach US$ 4.58 Bn by 2030, from US$ 2.70 Bn in 2023, exhibiting a CAGR of 7.8% during the forecast period.

Figure 1. Global Antidote Market Share (%), By Region, 2023

The global antidote market has been witnessing steady growth over the past few years owing to the growing incidence of poisoning cases across the world. Poisoning can occur accidentally or intentionally through the consumption of toxic chemicals, drugs, or other harmful substances. Antidotes are pharmaceutical preparations administered to counteract the effects of poisons, toxins, or certain disease states. They work by blocking the mechanisms through which poisons produce their toxic effects in the body. With rising environmental pollution and drug abuse in modern times, the need for effective antidotal treatments for poisoning is increasing continuously. The market offers a wide range of antidotes for common poisoning cases involving opioids, organophosphates, methanol, chloroquine, and other toxic agents. Leading players are focusing on developing novel formulations with better efficacy and safety profiles to cater to unmet needs.

Market Dynamics:

The increasing incidence of accidental and intentional poisoning worldwide is a major driver for the antidote market. Growing environmental pollution and industrial waste have simultaneously increased exposure to toxic chemicals. A significant rise in substance abuse disorders has also heightened poisoning risks from overdoses of prescription medications and recreational drugs. However, high costs associated with antidote production, the short shelf life of some products, and the lack of availability in remote regions restrict broader market uptake to some extent. On the other hand, ongoing research and development into advanced therapeutic alternatives and expanding healthcare access in emerging nations are expected to create new opportunities. The development of antidotes for specialty toxins and bioterrorism agents also holds promising prospects. For instance, in March 2022, according to a report published by the National Center for Biotechnology Information, approximately 121,729 fatalities were reported due to drug overdose in 2021, in the U.S. Additionally, the rising occurrence of medical issues that require the use of antidotes, including preventative treatment for pneumonia, aid in quitting smoking, treatment for toxoplasmosis, countering opioid overdose, reversing opioid-induced sedation, addressing trichotillomania, and reversing sedation, is propelling market expansion.

Key features of the study:

• This report provides in-depth analysis of the global antidote market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global antidote market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Dr. Reddy's Laboratories Ltd Viatris Inc., Fresenius Kabi AG, Zydus Lifesciences Ltd., Endo International plc, Novartis AG, Baxter International, Inc., Emergent BioSolutions Inc., Pfizer Inc., Hikma Pharmaceuticals PLC, Incepta Pharma, VINS Bioproducts Ltd Bharat Serums and Vaccines Limited, CSL Limited, Mediclone Biotech, Shanghai Serum Bio-technology Co., LTD., Haffkine Bio-pharmaceutical Corporation Ltd. and Premium Serums
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global antidote market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antidote market

Detailed Segmentation:

• Global Antidote Market, By Type
  • Chemical Antidote
  • Physical Antidote
  • Pharmacological Antidote
• Global Antidote Market, By Route of Administration
  • Oral
  • Topical
  • Injectable
  • Others
• Global Antidote Market, By End User
  • Hospitals
  • Speciality Clinics
  • Others
• Global Antidote Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Global Antidote Market, Key Players
  • Reddy's Laboratories Ltd
  • Viatris Inc.
  • Fresenius Kabi AG
  • Zydus Lifesciences Ltd.
  • Endo International plc
  • Novartis AG
  • Baxter International, Inc.
  • Emergent BioSolutions Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Incepta Pharma
  • VINS Bioproducts Ltd
  • Bharat Serums and Vaccines Limited
  • CSL Limited
  • Mediclone Biotech
  • Shanghai Serum Bio-technology Co., LTD.
  • Haffkine Bio-pharmaceutical Corporation Ltd.
  • Premium Serums

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Antidote Market, By Type
  • Global Antidote Market, By Route of Administration
  • Global Antidote Market, By End User
  • Global Antidote Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in cases of accidental poisoning
  • Stringent regulations for approval of antidotes
  • Increasing demand for generic antidotes
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Antidote Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Antidote Market, By Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Chemical Antidote
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Physical Antidote
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Pharmacological Antidote
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Antidote Market, By Route of Administration, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Antidote Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Speciality Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Antidote Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Reddy's Laboratories Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fresenius Kabi AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Zydus Lifesciences Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endo International plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
• Baxter International, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Emergent BioSolutions Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Incepta Pharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• VINS Bioproducts Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bharat Serums and Vaccines Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CSL Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mediclone Biotech
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Shanghai Serum Bio-technology Co., LTD.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Haffkine Bio-pharmaceutical Corporation Ltd.
• Premium Serums
• Analyst Views

10. Section

• Research Methodology
• About us